- Newsletter
- October 2026
- 2 Pages
Global
From €121EUR$131USD£101GBP
- Report
- March 2026
- 80 Pages
From €3188EUR$3,450USD£2,670GBP
- Report
- February 2026
- 76 Pages
From €3188EUR$3,450USD£2,670GBP
- Report
- October 2025
- 87 Pages
Kuwait
From €4158EUR$4,500USD£3,482GBP
- Report
- October 2025
- 89 Pages
Qatar
From €4158EUR$4,500USD£3,482GBP
- Report
- October 2025
- 146 Pages
Global
From €4481EUR$4,850USD£3,753GBP
- Report
- September 2025
- 140 Pages
Global
From €4481EUR$4,850USD£3,753GBP
- Report
- September 2025
- 140 Pages
Global
From €4481EUR$4,850USD£3,753GBP
- Report
- August 2025
- 109 Pages
Global
From €3188EUR$3,450USD£2,670GBP
- Report
- August 2025
- 73 Pages
Middle East, Africa
From €3188EUR$3,450USD£2,670GBP
- Report
- August 2025
- 73 Pages
From €3188EUR$3,450USD£2,670GBP
- Report
- August 2025
- 97 Pages
Asia Pacific
From €3649EUR$3,950USD£3,057GBP
- Report
- August 2025
- 98 Pages
Europe
From €3649EUR$3,950USD£3,057GBP
- Report
- August 2025
- 89 Pages
North America
From €3188EUR$3,450USD£2,670GBP
- Report
- August 2025
- 197 Pages
Global
From €4573EUR$4,950USD£3,831GBP
- Report
- August 2025
- 20 Pages
Global
From €16626EUR$17,995USD£13,926GBP
- Report
- June 2025
- 210 Pages
Global
From €4481EUR$4,850USD£3,753GBP
- Report
- June 2025
- 135 Pages
Global
From €4481EUR$4,850USD£3,753GBP
- Report
- June 2025
- 210 Pages
Global
From €4158EUR$4,500USD£3,482GBP
- Report
- April 2025
- 140 Pages
Global
From €4481EUR$4,850USD£3,753GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more